{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:36:26Z","timestamp":1779348986692,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cbi.2022.110244","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T03:23:29Z","timestamp":1667445809000},"page":"110244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1839-1049","authenticated-orcid":false,"given":"J.A.","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Arboleda-Bustos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pinzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110244_bib2","first-page":"4","article-title":"The N501Y and K417N mutations in the spike protein of SARS-CoV-2 alter the interactions with both hACE2 and human-derived antibody: a Free energy of perturbation study","author":"Fratev","year":"2020","journal-title":"bioRxiv : The Preprint Server for Biology"},{"issue":"1","key":"10.1016\/j.cbi.2022.110244_bib3","first-page":"1","article-title":"An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants","volume":"11","author":"Tanaka","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2022.110244_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.61312","article-title":"Escape from neutralizing antibodies 1 by SARS-CoV-2 spike protein variants","volume":"9","author":"Weisblum","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.cbi.2022.110244_bib5","first-page":"19","article-title":"Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant","author":"Deng","year":"2020","journal-title":"Ann. Oncol."},{"issue":"7855","key":"10.1016\/j.cbi.2022.110244_bib6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110244_bib8","series-title":"Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant Is Prevalent - Wisconsin","author":"Riemersma","year":"2021"},{"issue":"14","key":"10.1016\/j.cbi.2022.110244_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147425","article-title":"Structural evaluation of the spike glycoprotein variants on SARS-CoV-2 transmission and immune evasion","volume":"22","author":"Salleh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cbi.2022.110244_bib10","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/j.cell.2021.02.033","article-title":"Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera","volume":"184","author":"Supasa","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2022.110244_bib11","article-title":"Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa","volume":"2","author":"Tegally","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.cbi.2022.110244_bib12","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3780277","article-title":"Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69\/V70","author":"Kemp","year":"2021","journal-title":"SSRN Electron. J."},{"key":"10.1016\/j.cbi.2022.110244_bib13","article-title":"Variants of SARS-CoV-2","author":"Lauring","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cbi.2022.110244_bib14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.cbi.2022.110244_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41423-020-0458-z","article-title":"Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies","volume":"17","author":"Yi","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.cbi.2022.110244_bib16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution","volume":"6","author":"Zahradn\u00edk","year":"2021","journal-title":"Nature Microbiology"},{"key":"10.1016\/j.cbi.2022.110244_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-021-03426-1","article-title":"CMMID COVID-19 Working Group. et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7","volume":"593","author":"Davies","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110244_bib18","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(21)01358-1","article-title":"SARS-CoV-2 delta VOC in scotland: demographics, risk of hospital admission, and vaccine effectiveness","volume":"397","author":"Sheikh","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.cbi.2022.110244_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJMoa2108891","article-title":"Effectiveness of covid-19 vaccines against the B.1.617.2 (delta) variant","volume":"385","author":"Bernal","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"7898","key":"10.1016\/j.cbi.2022.110244_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110244_bib1","doi-asserted-by":"crossref","DOI":"10.12998\/wjcc.v10.i1.1","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance","author":"Ren","year":"2022","journal-title":"World J. Clin. Cases"},{"issue":"10","key":"10.1016\/j.cbi.2022.110244_bib21","first-page":"640","article-title":"Risikofaktor Komorbidit\u00e4ten bei COVID-19- Erkrankung","volume":"74","author":"Guang","year":"2020","journal-title":"Pneumologie"},{"issue":"March","key":"10.1016\/j.cbi.2022.110244_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.cbi.2022.110244_bib23","first-page":"8787","article-title":"Genetic gateways to COVID-19 infection: implications for risk, severity, and outcomes","volume":"34","author":"Debnath","year":"2020","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"issue":"6485","key":"10.1016\/j.cbi.2022.110244_bib24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Renhong","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cbi.2022.110244_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"Issue 21","key":"10.1016\/j.cbi.2022.110244_bib26","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1021\/acs.jpcb.1c02048","article-title":"Critical interactions between the SARS-CoV-2 spike glycoprotein and the human ACE2 receptor","volume":"125","author":"Taka","year":"2021","journal-title":"J. Phys. Chem. B"},{"issue":"11","key":"10.1016\/j.cbi.2022.110244_bib27","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41431-020-0691-z","article-title":"ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population","volume":"28","author":"Benetti","year":"2020","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2022.110244_bib28","series-title":"Molecular Docking Simulation Reveals ACE2 Polymorphisms that May Increase the Affinity of ACE2 with the SARS-CoV-2 Spike Protein","author":"Calcagnile","year":"2020"},{"issue":"1","key":"10.1016\/j.cbi.2022.110244_bib29","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discovery"},{"issue":"9","key":"10.1016\/j.cbi.2022.110244_bib30","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/jmv.25832","article-title":"Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein","volume":"92","author":"Hussain","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2022.110244_bib68","series-title":"Data, Disease, and Diplomacy : GISAID's Innovative Contribution to Global Health","first-page":"33","author":"Elbe","year":"2017"},{"issue":"7807","key":"10.1016\/j.cbi.2022.110244_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2022.110244_bib32","series-title":"Key Interacting Residues between RBD of SARS-CoV - 2 and ACE2 Receptor: Combination of Molecular Dynamics Simulation and Density Functional Calculation","author":"Jawad","year":"2021"},{"issue":"19","key":"10.1016\/j.cbi.2022.110244_bib33","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1042\/BCJ20200908","article-title":"Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain","volume":"478","author":"Low-Gan","year":"2021","journal-title":"Biochem. J."},{"issue":"6891","key":"10.1016\/j.cbi.2022.110244_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"issue":"7809","key":"10.1016\/j.cbi.2022.110244_bib35","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1016\/j.cbi.2022.110244_bib36","first-page":"S5","article-title":"iStable: off-the-shelf predictor integration for predicting protein stability changes","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.cbi.2022.110244_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/nar\/gkl190","article-title":"CUPSAT: prediction of protein stability upon point mutations","volume":"34","author":"Parthiban","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.cbi.2022.110244_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.10104","article-title":"Increasing the precision of comparative models with YASARA NOVA - a self-parameterizing force field","volume":"47","author":"Krieger","year":"2002","journal-title":"Proteins Struct. Funct. Genet."},{"key":"10.1016\/j.cbi.2022.110244_bib39","series-title":"The PyMOL Molecular Graphics System","author":"Schr\u00f6dinger","year":"2015"},{"issue":"5","key":"10.1016\/j.cbi.2022.110244_bib40","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","article-title":"The HDOCK server for integrated protein\u2013protein docking","volume":"15","author":"Yan","year":"2020","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.cbi.2022.110244_bib41","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/bioinformatics\/btz828","article-title":"QMEANDisCo\u2014distance constraints applied on model quality estimation","volume":"36","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"issue":"23","key":"10.1016\/j.cbi.2022.110244_bib42","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein-protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"issue":"JULY2015","key":"10.1016\/j.cbi.2022.110244_bib43","first-page":"1","article-title":"Contacts-based prediction of binding affinity in protein\u2013protein complexes","volume":"4","author":"Vangone","year":"2015","journal-title":"Elife"},{"issue":"18","key":"10.1016\/j.cbi.2022.110244_bib44","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/bioinformatics\/btn353","article-title":"Accurate prediction of stability changes in protein mutants by combining machine learning with structure based computational mutagenesis","volume":"24","author":"Masso","year":"2008","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cbi.2022.110244_bib45","first-page":"1954","volume":"vol. 89","author":"Li","year":"2015"},{"issue":"8","key":"10.1016\/j.cbi.2022.110244_bib46","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.emboj.7600640","article-title":"Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2","volume":"24","author":"Li","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.cbi.2022.110244_bib47","series-title":"Evolutionary and Structural Analysis Elucidates Mutations on SARS-CoV2 Spike Protein with Altered Human ACE2 Binding Affinity","author":"Chellasamy","year":"2020"},{"key":"10.1016\/j.cbi.2022.110244_bib48","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1016\/j.csbj.2020.11.002","article-title":"Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization","volume":"18","author":"Shah","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6483","key":"10.1016\/j.cbi.2022.110244_bib49","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cbi.2022.110244_bib50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s15010-020-01516-2","article-title":"COVID-19 outbreak: history, mechanism, transmission, structural studies and therapeutics","volume":"49","author":"Yesudhas","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.cbi.2022.110244_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00863-2","article-title":"SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2","author":"Wu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6511","key":"10.1016\/j.cbi.2022.110244_bib52","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy","volume":"369","author":"Gu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cbi.2022.110244_bib53","series-title":"Antibody Evasion by the P . 1 Strain of SARS-CoV-2","first-page":"2939","author":"Dejnirattisai","year":"2021"},{"key":"10.1016\/j.cbi.2022.110244_bib54","series-title":"The Lambda Variant of SARS-CoV-2 Has a Better Chance than the Delta Variant to Escape Vaccines","first-page":"1","author":"Liu","year":"2021"},{"issue":"8","key":"10.1016\/j.cbi.2022.110244_bib55","first-page":"1","article-title":"Probing the increased virulence of severe acute respiratory syndrome coronavirus 2 B.1.617 (Indian variant) from predicted spike protein structure","volume":"617","author":"Hajj-Hassan","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.cbi.2022.110244_bib56","series-title":"The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity","author":"Li","year":"2020"},{"issue":"1","key":"10.1016\/j.cbi.2022.110244_bib57","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1038\/s41467-022-33068-4","article-title":"The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition","volume":"13","author":"Motozono","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cbi.2022.110244_bib58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"12","key":"10.1016\/j.cbi.2022.110244_bib59","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1039\/D2RA00277A","article-title":"Blocking key mutated hotspot residues in the RBD of the omicron variant (B.1.1.529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches","volume":"12","author":"Khan","year":"2022","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.cbi.2022.110244_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2022.110466","article-title":"SARS-CoV-2 VOCs, Mutational diversity and clinical outcome: are they modulating drug efficacy by altered binding strength?","volume":"114","author":"Saifi","year":"2022","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.cbi.2022.110244_bib61","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mco2.110","article-title":"SARS-CoV-2 Omicron variant: characteristics and prevention","volume":"2","author":"He","year":"2020","journal-title":"MedComm"},{"issue":"6508","key":"10.1016\/j.cbi.2022.110244_bib62","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1126\/science.abc0870","article-title":"Engineering Human ACE2 to optimize binding to the spike protein of SARS coronavirus 2","volume":"369","author":"Chan","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cbi.2022.110244_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-021-02030-3","article-title":"Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2","volume":"4","author":"Suryamohan","year":"2021","journal-title":"Communications Biology"},{"key":"10.1016\/j.cbi.2022.110244_bib64","series-title":"Human ACE2 Receptor Polymorphisms Predict SARS-CoV-2 Susceptibility","author":"Stawiski","year":"2020"},{"issue":"2","key":"10.1016\/j.cbi.2022.110244_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06133","article-title":"ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: a time to implement precision medicine against COVID-19","volume":"7","author":"Al-Mulla","year":"2021","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.cbi.2022.110244_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-020-00374-6","article-title":"Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID-19","volume":"5","author":"Abd El-Aziz","year":"2020","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722004495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722004495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:17:58Z","timestamp":1757859478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722004495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":66,"alternative-id":["S0009279722004495"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110244","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110244"}}